ArticleDiabetes, obesity & metabolism2026
Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial.
Hwee Teoh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.